JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

Overview of attention for article published in Breast Cancer Research, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 96 Dimensions

Readers on

mendeley: 56 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

A JMJD6 TARGETING AGENT FOR TREATING PROSTATE CANCER

Application WO-2022129935-A1

World Intellectual Property Organisation (WIPO)

A BIOMARKER AND TREATMENT FOR CANCER

Application EP-2403963-A4

European Patent Office

A BIOMARKER AND TREATMENT FOR CANCER

Application EP-2403963-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.